These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9042140)

  • 1. Prolonged extreme thrombocytosis associated with neurofibromatosis type 1.
    Hasle H; Nir M; Tommerup N
    J Pediatr; 1997 Feb; 130(2):317-9. PubMed ID: 9042140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1.
    Legius E; Descheemaeker MJ; Fryns JP; Van den Berghe H
    Genet Couns; 1994; 5(3):225-41. PubMed ID: 7811422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.
    Jenne DE; Tinschert S; Reimann H; Lasinger W; Thiel G; Hameister H; Kehrer-Sawatzki H
    Am J Hum Genet; 2001 Sep; 69(3):516-27. PubMed ID: 11468690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a single base-pair deletion in neurofibromatosis type 1.
    Colman SD; Collins FS; Wallace MR
    Hum Mol Genet; 1993 Oct; 2(10):1709-11. PubMed ID: 8268926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis.
    Xu W; Mulligan LM; Ponder MA; Liu L; Smith BA; Mathew CG; Ponder BA
    Genes Chromosomes Cancer; 1992 Jun; 4(4):337-42. PubMed ID: 1377942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism.
    Kayes LM; Riccardi VM; Burke W; Bennett RL; Stephens K
    J Med Genet; 1992 Oct; 29(10):686-90. PubMed ID: 1359144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region.
    Kehrer-Sawatzki H; Tinschert S; Jenne DE
    J Med Genet; 2003 Oct; 40(10):e116. PubMed ID: 14569139
    [No Abstract]   [Full Text] [Related]  

  • 9. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association.
    Bahuau M; Flintoff W; Assouline B; Lyonnet S; Le Merrer M; Prieur M; Guilloud-Bataille M; Feingold N; Munnich A; Vidaud M; Vidaud D
    Am J Med Genet; 1996 Dec; 66(3):347-55. PubMed ID: 8985499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17q inversion involving the neurofibromatosis type one locus in a family with neurofibromatosis type one.
    Asamoah A; North K; Doran S; Wagstaff J; Ogle R; Collins FS; Korf BR
    Am J Med Genet; 1995 Aug; 60(4):312-6. PubMed ID: 7485267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a cytogenetic 17q11.2 deletion in an NF1 patient with a contiguous gene syndrome.
    Riva P; Castorina P; Manoukian S; Dalprà L; Doneda L; Marini G; den Dunnen J; Larizza L
    Hum Genet; 1996 Dec; 98(6):646-50. PubMed ID: 8931693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay.
    Upadhyaya M; Roberts SH; Maynard J; Sorour E; Thompson PW; Vaughan M; Wilkie AO; Hughes HE
    J Med Genet; 1996 Feb; 33(2):148-52. PubMed ID: 8929953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF1 gene and neurofibromatosis 1.
    Rasmussen SA; Friedman JM
    Am J Epidemiol; 2000 Jan; 151(1):33-40. PubMed ID: 10625171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2.
    Streubel B; Latta E; Kehrer-Sawatzki H; Hoffmann GF; Fonatsch C; Rehder H
    Am J Med Genet; 1999 Nov; 87(1):12-6. PubMed ID: 10528240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
    Legius E; Marchuk DA; Collins FS; Glover TW
    Nat Genet; 1993 Feb; 3(2):122-6. PubMed ID: 8499945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme thrombocytosis associated with transient myeloproliferative disorder with Down Syndrome with t(11;17)(q13;q21).
    Park ES; Kim SY; Yeom JS; Lim JY; Park CH; Youn HS
    Pediatr Blood Cancer; 2008 Mar; 50(3):643-4. PubMed ID: 16941648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended runs of homozygosity at 17q11.2: an association with type-2 NF1 deletions?
    Roehl AC; Cooper DN; Kluwe L; Helbrich A; Wimmer K; Högel J; Mautner VF; Kehrer-Sawatzki H
    Hum Mutat; 2010 Mar; 31(3):325-34. PubMed ID: 20052761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial neurofibromatosis type 1 associated with an overgrowth syndrome resembling Weaver syndrome.
    van Asperen CJ; Overweg-Plandsoen WC; Cnossen MH; van Tijn DA; Hennekam RC
    J Med Genet; 1998 Apr; 35(4):323-7. PubMed ID: 9598729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.